Shahbaz Ul Haq | Medical Hypotheses | Best Researcher Award

Postdoctoral at Shantou university medical college, China

Dr. Shahbaz Ul Haq is an accomplished veterinary scientist and postdoctoral researcher at Shantou University Medical College, China. With a Ph.D. in Basic Veterinary Medicine from the Chinese Academy of Agricultural Sciences, his work focuses on antimicrobial resistance (AMR) and zoonotic infections. His groundbreaking research investigates the synergistic potential of artemisinin derivatives to boost antibiotic efficacy against multidrug-resistant E. coli. Dr. Haq has held technical leadership roles in Pakistan’s veterinary industry, implementing evidence-based treatment protocols and exploring alternatives to antibiotics in livestock. He has authored impactful publications in top-tier journals like Frontiers in Veterinary Science and European Journal of Pharmacology. Dr. Haq has also been honored as a “Shantou High-Level Talent” and received the “Best Researcher Award” by ScienceFather. With international training, collaborative projects, and a strong publication record, he is a recognized authority in veterinary microbiology and One Health.

Publication Profile

Google Scholar

Education

Dr. Shahbaz Ul Haq holds a Ph.D. in Basic Veterinary Medicine from the Chinese Academy of Agricultural Sciences (2018–2022), where he focused on enhancing antibiotic activity through artemisinin derivatives. His coursework included advanced studies in immunology, microbiology, veterinary epidemiology, and Chinese culture. He earned his M.Phil. in Clinical Medicine and Surgery from the University of Agriculture, Faisalabad (2016–2018), conducting a comparative study on udder edema in dairy goats. Earlier, he completed a Doctor of Veterinary Medicine (DVM) degree from the same university (2010–2015), with a strong foundation in parasitology, virology, public health, and pathology. His academic path reflects a consistent emphasis on veterinary health, disease management, and clinical research. He also undertook several international workshops and advanced trainings in veterinary diagnostics, AMR surveillance, and zoonotic disease control across China, Morocco, Italy, and Pakistan.

Experience

Dr. Haq currently serves as a Postdoctoral Researcher at Shantou University Medical College, China, where his research addresses multidrug-resistant bacteria and antibiotic resistance. Previously, he worked as a Technical Manager at Polaris Life Sciences in Pakistan (2022–2023), focusing on reducing antibiotic residues in food through alternatives like probiotics. As Technical Executive at Forward Solutions (2015–2016), he explored mineral supplementation and metabolic disorders in livestock. He also interned at Sarbuland Dairy Farm, learning dairy management protocols. Dr. Haq has actively contributed to project proposals under the China Postdoctoral Science Foundation and National Natural Science Fund of China. He has participated as a speaker in numerous international conferences and workshops on animal health, veterinary biotechnology, and traditional medicine. With strong field and laboratory experience, he bridges academic research and real-world veterinary challenges.

Awards and Honors

Dr. Shahbaz Ul Haq has received notable national and international recognition for his research contributions. He was honored as a “Shantou High-Level Talent” in China, a prestigious recognition of exceptional scientific contributions. In 2025, he received the “Best Researcher Award” in Traditional Medicine from ScienceFather. He also serves as an Editorial Board Member for the New Scientists Awards, under Scifax Company Group. His academic journey was supported by competitive scholarships, including the Chinese Government Scholarship (CGS) for his Ph.D., and the Punjab Educational Endowment Fund (PEEF) for his M.Phil. Dr. Haq has presented at numerous international forums, including conferences in Italy, Morocco, China, and Pakistan. His participation in postdoctoral research forums and his leadership in AMR-focused projects further solidify his standing as a rising global voice in veterinary science and One Health research.

Research Focus

Dr. Haq’s research is centered on antimicrobial resistance (AMR), zoonotic pathogens, and veterinary pharmacology. His Ph.D. research demonstrated the synergistic effect of artemisinin derivatives in enhancing β-lactam and fluoroquinolone efficacy against multidrug-resistant E. coli, offering new hope in the fight against AMR. At Shantou University, his postdoctoral work continues to explore novel combinations of natural compounds and conventional antibiotics. Dr. Haq is also active in genetic epidemiology, studying mitochondrial gene variation in zoonotic parasites like Taenia multiceps, Clonorchis sinensis, and Echinococcus granulosus. His work integrates bioinformatics, microbial genomics, drug resistance profiling, and public health risk assessment. In applied veterinary settings, he has led research into probiotic alternatives, parasite control, and clinical treatment protocols to reduce antibiotic residues in livestock products. His interdisciplinary approach spans One Health, molecular microbiology, and pharmacogenomics.

Publication Top Notes

Revealing novel cytb and nad5 genes-based population diversity and benzimidazole resistance in Echinococcus granulosus of bovine origin

Anticoccidial Activity of Qinghao Powder Against Eimeria tenella in Broiler Chickens

Toxicological evaluation of the ultrasonic extract from Dichroae radix in mice and wistar rats

Regulation and analysis of the diversity of intestinal microbiota in SD rats by Danggui Buxue Tang (DBT) fermented with Bacillus subtilis

Drug resistance modulation of dairy MRSA through Berberine. Artesunate and Quercetin in Combination with β-Lactams

Subclinical Mastitis in Small-Holder Dairy Herds of Gansu Province, Northwest China: Prevalence, Bacterial Pathogens, Antimicrobial Susceptibility, and Risk Factor Analysis

Comparison of photosensitized tissue bonding and vet glue in closure of incisional wounds.

Xuemin Jin | Medical Hypotheses | Best Researcher Award

Assoc. Prof. Dr Xuemin Jin, Jilin University, China

Assoc. Prof. Dr. Xuemin Jin is a leading scientist in the field of veterinary parasitology and zoonotic diseases. With over a decade of research experience, she has contributed significantly to understanding host–parasite–microbiome interactions, helminth immunology, and vaccine development. Currently an Associate Professor at the Institute of Zoonoses, Jilin University, she holds key roles in national and international scientific bodies, such as the International Commission on Trichinosis and the OIE Collaborating Centre for Foodborne Parasitic Diseases. Her work bridges parasitology, microbiota, and immunology, with her findings published in high-impact journals like Signal Transduction and Targeted Therapy, Gut Microbes, and PLoS Pathogens. A recipient of several prestigious grants from China’s National Natural Science Foundation and the Ministry of Science and Technology, Dr. Jin is a recognized leader advancing the frontiers of zoonotic parasitic disease research.

Education

Dr. Xuemin Jin completed her academic training entirely at Jilin University, one of China’s top veterinary and medical research institutions. She earned her Bachelor of Science (B.S.) in Veterinary Medicine from the College of Veterinary Medicine in 2015. She then pursued a Ph.D. in Veterinary Parasitology, completed in 2020, where she explored the molecular and immunological mechanisms of Trichinella spiralis. Following her doctorate, she continued her scholarly path as a Postdoctoral Fellow from 2020 to 2022 at the Institute of Zoonoses, Jilin University, where she specialized in zoonotic parasitic infections and host-pathogen interactions. Her academic trajectory showcases a strong foundation in experimental parasitology, immunomodulation, and zoonotic disease control strategies.

Experience

Dr. Jin began her academic career as a Lecturer at the College of Veterinary Medicine, Jilin University (2020–2022), contributing to teaching and mentoring in parasitology and immunopathology. Since 2022, she has been serving as an Associate Professor at the Institute of Zoonoses, where she leads research on Trichinella spiralis and intestinal helminth-microbiota interactions. She plays a key role in collaborative vaccine development initiatives and oversees multiple research grants. Additionally, she has held notable academic positions including committee memberships in the 8th Veterinary Discipline Evaluation Group of the State Council, OIE Collaborating Centre, and the International Commission on Trichinosis. These roles highlight her credibility and thought leadership in the field.

Awards and Honors

Dr. Jin has received multiple accolades through prestigious national-level funding, including leading and sub-leading roles in National Natural Science Foundation of China’s Key Program and 14th Five-Year Plan Key R&D Projects by the Ministry of Science and Technology. These grants, totaling millions of RMB, underscore the scientific community’s trust in her expertise. She serves as a Committee Member for global parasitology initiatives such as the International Commission on Trichinosis, and holds national recognition through the Veterinary Discipline Evaluation Group of the Academic Degrees Committee of the State Council. Her continuous engagement in international and policy-level scientific networks highlights her influential status in zoonotic and veterinary research.

Research Focus

Dr. Jin’s primary research centers on zoonotic parasitic diseases, particularly Trichinella spiralis, integrating host immunity, microbiome regulation, and vaccine development. Her work reveals novel immunological mechanisms, such as the role of β-glucans and intestinal bacteria (e.g., Akkermansia muciniphila) in modulating helminth-induced pathology and immune responses. She has made groundbreaking findings in TLR2/NLRP3-mediated pathways, host-protective immunity, and the cross-talk between helminths and commensal gut bacteria. Additionally, she contributes to the development of recombinant and genetically engineered vaccines for zoonotic infections, aligning with global One Health strategies. Her research is interdisciplinary, with applications in veterinary public health, immunology, and parasitic disease control.